210 related articles for article (PubMed ID: 2933632)
1. Prenatal diagnosis of GM2 gangliosidosis with high residual hexosaminidase A activity (variant B1; pseudo AB variant).
Conzelmann E; Nehrkorn H; Kytzia HJ; Sandhoff K; Macek M; Lehovský M; Elleder M; Jirásek A; Kobilková J
Pediatr Res; 1985 Nov; 19(11):1220-4. PubMed ID: 2933632
[TBL] [Abstract][Full Text] [Related]
2. Variant of GM2-gangliosidosis with hexosaminidase A having a severely changed substrate specificity.
Kytzia HJ; Hinrichs U; Maire I; Suzuki K; Sandhoff K
EMBO J; 1983; 2(7):1201-5. PubMed ID: 6226523
[TBL] [Abstract][Full Text] [Related]
3. Genetic complementation in somatic cell hybrids of four variants of infantile GM2 gangliosidosis.
Sonderfeld S; Brendler S; Sandhoff K; Galjaard H; Hoogeveen AT
Hum Genet; 1985; 71(3):196-200. PubMed ID: 2933318
[TBL] [Abstract][Full Text] [Related]
4. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level.
Conzelmann E; Kytzia HJ; Navon R; Sandhoff K
Am J Hum Genet; 1983 Sep; 35(5):900-13. PubMed ID: 6614006
[TBL] [Abstract][Full Text] [Related]
5. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts.
O'Brien JS; Norden GW; Miller AL; Frost RG; Kelly TE
Clin Genet; 1977 Mar; 11(3):171-83. PubMed ID: 13950
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of infantile and juvenile forms of GM2 gangliosidosis variant 0. Residual activities toward natural and different synthetic substrates.
Kytzia HJ; Hinrichs U; Sandhoff K
Hum Genet; 1984; 67(4):414-8. PubMed ID: 6436167
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes.
Bayleran J; Hechtman P; Saray W
Clin Chim Acta; 1984 Nov; 143(2):73-89. PubMed ID: 6239713
[TBL] [Abstract][Full Text] [Related]
8. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
Charrow J; Binns HJ
Clin Chim Acta; 1986 Apr; 156(1):41-9. PubMed ID: 2938852
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and molecular aspects of late-onset GM2-gangliosidosis: B1 variant as a prototype.
Suzuki K; Vanier MT
Dev Neurosci; 1991; 13(4-5):288-94. PubMed ID: 1840099
[TBL] [Abstract][Full Text] [Related]
10. Prenatal diagnosis of GM2-gangliosidosis B1 variant.
Lemos M; Pinto R; Ribeiro G; Ribeiro H; Lopes L; Sá Miranda MC
Prenat Diagn; 1995 Jun; 15(6):585-8. PubMed ID: 7659693
[TBL] [Abstract][Full Text] [Related]
11. Late onset GM2 gangliosidosis: an alpha-locus genetic compound with near normal hexosaminidase activity.
Charrow J; Inui K; Wenger DA
Clin Genet; 1985 Jan; 27(1):78-84. PubMed ID: 3156697
[TBL] [Abstract][Full Text] [Related]
12. Frequency of hexosaminidase A variant alleles among Ashkenazi Jews and prenatal diagnosis of GM2 gangliosidosis.
Navon R; Adam A
Am J Hum Genet; 1985 Sep; 37(5):1031-3. PubMed ID: 2931975
[No Abstract] [Full Text] [Related]
13. AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.
Conzelmann E; Sandhoff K
Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3979-83. PubMed ID: 99746
[TBL] [Abstract][Full Text] [Related]
14. Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein.
Inui K; Grebner EE; Jackson LG; Wenger DA
Am J Hum Genet; 1983 Jul; 35(4):551-64. PubMed ID: 6224417
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of two variants of type-AB GM2-gangliosidosis using chromogenic substrates.
Li YT; Hirabayashi Y; Li SC
Am J Hum Genet; 1983 May; 35(3):520-2. PubMed ID: 6222647
[TBL] [Abstract][Full Text] [Related]
16. Adult-onset GM2 gangliosidosis diagnosed in a fetus.
Navon R; Sandbank U; Frisch A; Baram D; Adam A
Prenat Diagn; 1986; 6(3):169-76. PubMed ID: 2941730
[TBL] [Abstract][Full Text] [Related]
17. The protein activator specific for the enzymic hydrolysis of GM2 ganglioside in normal human brain and brains of three types of GM2 gangliosidosis.
Hirabayashi Y; Li YT; Li SC
J Neurochem; 1983 Jan; 40(1):168-75. PubMed ID: 6848657
[TBL] [Abstract][Full Text] [Related]
18. Use of microtechniques for the detection of lysosomal enzyme disorders: Tay-Sachs disease, Gm1-gangliosidosis and Fabry disease.
Bladon MT; Milunsky A
Clin Genet; 1978 Dec; 14(6):359-66. PubMed ID: 215359
[TBL] [Abstract][Full Text] [Related]
19. Prenatal diagnosis of Tay-Sachs disease. Reflectometry of hexosaminidase A, B, and C/S bands on zymograms.
Kustermann-Kuhn B; Harzer K
Hum Genet; 1983; 65(2):172-5. PubMed ID: 6228513
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of 4-methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy-beta-D-glucopyrano sid e for the diagnosis of GM2 gangliosidoses in leukocytes.
Inui K; Wenger DA
Clin Genet; 1984 Oct; 26(4):318-21. PubMed ID: 6238730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
